Fundamental dimension Equity attribute | BKUHLeader $0.0010.00% Cap $301.3KP/E -0.0x QuantScore28/100 | ACBMPeer $0.0260.00% Cap $1.56MP/E -10.8x QuantScore26/100 | AKOMPeer $0.04110.00% Cap $807.8KP/E -0.1x QuantScore25/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
53/100 |
50/100 |
43/100 |
Valuation Multiples, PEG & DCF upside | 0/100 | 33/100 | 0/100 |
Health Piotroski, Altman Z, leverage & liquidity | 23/100 | 20/100 | 23/100 |
Growth Revenue / earnings growth & margins | 36/100 | 0/100 | 33/100 |
Sentiment Analyst ratings, targets & revisions | — | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -0.0x | -10.8x | -0.1x |
Forward P/E (next FY) | — | — | — |
EV / EBITDA (TTM) | -0.7x | -9.3x | -8.7x |
Price / Sales | — | — | 28.4x |
Price / Free Cash Flow | -0.7x | -11.1x | -0.4x |
PEG ratio | -0.00 | 0.11 | -0.00 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 3 / 9 | 2 / 9 | 3 / 9 |
Altman Z-Score | -134.56 (Distress) | -12930.52 (Distress) | -3.42 (Distress) |
Total debt / equity | -0.72 | -0.87 | -7.14 |
Quick ratio | 0.0x | 0.0x | 0.0x |
Interest coverage | -51.8x | -15.9x | -10.1x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | — | — | -100.0% |
Net income growth YoY | +33.4% | -139.1% | +37.4% |
Gross margin (TTM) | 0.0% | 0.0% | 30.6% |
Operating margin (FY) | — | — | — |
FCF margin (FY) | — | — | — |
5. Trailing price performancePrice change over period |
1M return | 0.0% | 0.0% | 0.0% |
3M return | 0.0% | 0.0% | 0.0% |
6M return | 0.0% | 0.0% | 0.0% |
Year to date | -95.0% | +17.1% | -98.4% |
1Y return | -95.0% | +3614.3% | -98.4% |
3Y return | -99.9% | -98.3% | -98.4% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-0.0307 -3169.3% premium | $-0.0062 -124.0% premium | $-1.45 -3626.8% premium |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | — |